Aadi Bioscience, Inc.AADINASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-61.20M
↓ 109% below average
Average (9y)
$-29.27M
Historical baseline
Range
High:$-5.85M
Low:$-63.63M
CAGR
+14.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-61.20M | +3.8% |
| 2023 | $-63.63M | -27.1% |
| 2022 | $-50.08M | -122.9% |
| 2021 | $-22.47M | -76.9% |
| 2020 | $-12.70M | +47.3% |
| 2019 | $-24.09M | -312.1% |
| 2018 | $-5.85M | +69.1% |
| 2017 | $-18.89M | -19.3% |
| 2016 | $-15.83M | +11.7% |
| 2015 | $-17.93M | - |